NCT05574907View on ClinicalTrials.gov

Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)

NAActive, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

February 1, 2024

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

68Ga-FAPI PET/CT scan

Patients with suspected breast cancer underwent 68Ga-FAPI PET/CT after an injection of 74-148 MBq (2-4 mCi) 68Ga-FAPI to image lesions of breast cancer.

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER